In the training group, non-survivor group had higher TBIL, PT, INR, WBC, PCT, bacterial infection, HE, MELDs and lower PLT, TL1A, DR3 promoter methylation, PTA (P < 0.05). This evidence concerns the gene TNFRSF25 and hereditary elliptocytosis.